AU2017900496A0 - Compounds for Enhancing the Permeation of Active Pharmaceutical Ingredients through Skin - Google Patents

Compounds for Enhancing the Permeation of Active Pharmaceutical Ingredients through Skin

Info

Publication number
AU2017900496A0
AU2017900496A0 AU2017900496A AU2017900496A AU2017900496A0 AU 2017900496 A0 AU2017900496 A0 AU 2017900496A0 AU 2017900496 A AU2017900496 A AU 2017900496A AU 2017900496 A AU2017900496 A AU 2017900496A AU 2017900496 A0 AU2017900496 A0 AU 2017900496A0
Authority
AU
Australia
Prior art keywords
permeation
enhancing
skin
compounds
active pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2017900496A
Inventor
Matthew CALLAHAN
Eugene Cooper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Botanix Pharmaceuticals Inc
Original Assignee
Botanix Pharmaceuticals Inc
Filing date
Publication date
Application filed by Botanix Pharmaceuticals Inc filed Critical Botanix Pharmaceuticals Inc
Publication of AU2017900496A0 publication Critical patent/AU2017900496A0/en
Abandoned legal-status Critical Current

Links

AU2017900496A 2017-02-15 Compounds for Enhancing the Permeation of Active Pharmaceutical Ingredients through Skin Abandoned AU2017900496A0 (en)

Publications (1)

Publication Number Publication Date
AU2017900496A0 true AU2017900496A0 (en) 2017-03-02

Family

ID=

Similar Documents

Publication Publication Date Title
EP3638248A4 (en) Conjugates of active pharmaceutical ingredients
EP3481402A4 (en) Compounds, compositions, and methods for the treatment of disease
CA2956871C (en) Compounds active towards bromodomains
EP3484504A4 (en) Compounds, compositions, and methods for the treatment of disease
WO2016149401A3 (en) Piperazine carbamates and methods of making and using same
EP3256149A4 (en) Formulations for oral administration of active agents
EP3180118A4 (en) Systems and methods for synthesizing chemical products, including active pharmaceutical ingredients
EP3151923A4 (en) Clear compositions and methods for the delivery of active ingredients for skin care
EP3603642A4 (en) Pharmaceutical preparation
EP3093023A4 (en) Pharmaceutical composition for cancer treatment and pharmaceutical preparation for cancer treatment containing same composition as active ingredient
EP3354254A4 (en) Skin whitening composition containing beta-mangostin as active ingredient
EP3180993A4 (en) Composition for improving skin, containing pomegranate concentrate as active ingredient
EP3590514A4 (en) Medicinal preparation
EP3441080A4 (en) Pharmaceutical composition for wound healing containing substance p
EP3851121A4 (en) Human anti-il-33 monoclonal-antibody-containing pharmaceutical composition
EP3687551A4 (en) Fluoro substituted porphyrin compounds, pharmaceutical compositions comprising the same, and methods of preparing and using the same
IL260766B (en) Continuous complexation of active pharmaceutical ingredients
EP3646866A4 (en) Pharmaceutical preparation
EP3158998A4 (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
EP3391908A4 (en) Stabilized pharmaceutical composition containing pemetrexed or pharmaceutically acceptable salt thereof
EP3668991A4 (en) Nanocarriers for the delivery of active ingredients
EP3284743A4 (en) Heterocyclic-imidazole compounds, pharmaceutical compositions thereof, preparation method therefor and use thereof
EP3429589A4 (en) Pharmaceutical composition of nilotinib
EP3319980B8 (en) Formulations for improving the efficacy of hydrophobic drugs
EP3398608A4 (en) Pharmaceutical composition for preventing and treating cancer or cancer metastasis, containing pstl1 protein as active ingredient